Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      EMA panel recommends Merck Pfizers diabetes drug

      EMA panel recommends Merck Pfizer's diabetes drug

      Medical Dialogues Bureau29 Jan 2018 9:45 AM IST
      A European Medicines Agency panel recommended granting marketing approval to a diabetes drug developed by Merck & Co and Pfizer Inc.The...
      AbbVie wins US trial in lawsuit over AndroGel

      AbbVie wins US trial in lawsuit over AndroGel's risks

      Medical Dialogues Bureau29 Jan 2018 9:30 AM IST
      A federal jury in Chicago found AbbVie Inc not liable in a lawsuit by an Arizona man who claimed he had suffered a pulmonary embolism due to using the...
      US SEC files suit over possible insider trading on Bioverativ

      US SEC files suit over possible insider trading on Bioverativ

      Medical Dialogues Bureau29 Jan 2018 9:15 AM IST
      The U.S. Securities and Exchange Commission filed an insider trading lawsuit on Friday against “unknown traders” who it said engaged in “highly...
      Ajanta Pharma Q3 net profit up 3 percent at Rs 147.47 crore

      Ajanta Pharma Q3 net profit up 3 percent at Rs 147.47 crore

      Medical Dialogues Bureau28 Jan 2018 11:00 AM IST
      New Delhi: Drug firm Ajanta Pharma reported a 3.41 percent rise in its consolidated net profit to Rs 147.47 crore for the quarter ended December 31,...
      Glenmark Pharma presents preliminary biomarker data on GBR 1302

      Glenmark Pharma presents preliminary biomarker data on GBR 1302

      Medical Dialogues Bureau28 Jan 2018 10:30 AM IST
      Mumbai: Pharma Major, Glenmark Pharmaceuticals announced a presentation of preliminary biomarker findings from a Phase 1 study of GBR 1302...
      Torrent Pharma board okays hiking borrowing limit to Rs 15,000 crore

      Torrent Pharma board okays hiking borrowing limit to Rs 15,000 crore

      Medical Dialogues Bureau28 Jan 2018 10:15 AM IST
      Torrent Pharmaceuticals said its Board has approved a proposal to enhance borrowing limits from Rs 10,000 crore to Rs 15,000 crore.As per a BSE...
      RuPay ties up with OXXY to offer health benefits

      RuPay ties up with OXXY to offer health benefits

      Medical Dialogues Bureau28 Jan 2018 10:00 AM IST
      Mumbai: Rupay, part of National Payments Corporation of India (NPCI), has tied up with country's largest Healthcare Network OXXY to provide health...
      GSKs shingles vaccine gets green light from EMA panel

      GSK's shingles vaccine gets green light from EMA panel

      Medical Dialogues Bureau28 Jan 2018 9:45 AM IST
      GlaxoSmithKline’s shingles vaccine moved one step closer to market after a European Medicines Agency (EMA) panel gave a positive opinion on the drug,...
      Illumina wins 26.7 million dollars in patent fight with Roche unit Ariosa

      Illumina wins 26.7 million dollars in patent fight with Roche unit Ariosa

      Medical Dialogues Bureau28 Jan 2018 9:30 AM IST
      Gene testing company Illumina won a $26.7 million jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a subsidiary of Roche Holdings AG,...
      FDA clears radioactive drug for digestive tract cancer that killed Steve Jobs

      FDA clears radioactive drug for digestive tract cancer that killed Steve Jobs

      Medical Dialogues Bureau27 Jan 2018 10:36 AM IST
      The U.S. Food and Drug Administration approved a radioactive drug to treat the ultra-rare type of digestive tract cancer that killed Steve Jobs in...
      Dr Reddys Q3 net profit falls 38 percent to Rs 303 crore

      Dr Reddy's Q3 net profit falls 38 percent to Rs 303 crore

      Medical Dialogues Bureau27 Jan 2018 10:30 AM IST
      New Delhi: Dr Reddy's Laboratories posted a 38.51 percent decline in consolidated net profit at Rs 302.7 crore for the third quarter ended December...
      Roche wins EU panels recommendation for hemophilia drug

      Roche wins EU panel's recommendation for hemophilia drug

      Medical Dialogues Bureau27 Jan 2018 10:15 AM IST
      A European Union panel on Friday recommended approval of Roche’s Hemlibra to treat haemophilia in some patients after the Swiss drugmaker got the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok